Thoroughbred Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $398K | Sell |
|
|||||
|
2025
Q2 | $402K | Sell |
|
|||||
|
2025
Q1 | $1.36M | Sell |
|
|||||
|
2024
Q4 | $1.45M | Buy |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $1.42M | Buy |
|
|||||
|
2024
Q1 | $552K | Sell |
|
|||||
|
2023
Q4 | $1.21M | Sell |
|
|||||
|
2023
Q3 | $1.1M | Buy |
|
|||||
|
2023
Q2 | $754K | Hold |
|
|||||
|
2023
Q1 | $661K | Sell |
|
|||||
|
2022
Q4 | $625K | Sell |
|
|||||
|
2022
Q3 | $746K | Sell |
|
|||||
|
2022
Q2 | $883K | Hold |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $288K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $629K | Buy |
|
|||||
|
2019
Q4 | $569K | Buy |
|
|||||
|
2019
Q3 | $339K | Buy |
|
|||||
|
2019
Q2 | $268K | Buy |
|
|||||
|
2019
Q1 | $249K | Buy |
|